TMZ’s introduction, for instance, improved therapeutic outcomes; however, TMZ resistance in GBM—mediated by the overexpression of MGMT and alkylpurine-DNA-N glycosylase (APNG), which repair TMZ-induced DNA lesions and thereby prevent apoptosis—is now well documented [69]. Here, MGMT is linked to glioblastoma.